vs
Side-by-side financial comparison of Axsome Therapeutics, Inc. (AXSM) and Westrock Coffee Co (WEST). Click either name above to swap in a different company.
Westrock Coffee Co is the larger business by last-quarter revenue ($339.5M vs $196.0M, roughly 1.7× Axsome Therapeutics, Inc.). Westrock Coffee Co runs the higher net margin — -6.6% vs -14.6%, a 7.9% gap on every dollar of revenue. On growth, Axsome Therapeutics, Inc. posted the faster year-over-year revenue change (65.0% vs 48.3%). Westrock Coffee Co produced more free cash flow last quarter ($27.8M vs $-18.7M). Over the past eight quarters, Axsome Therapeutics, Inc.'s revenue compounded faster (61.7% CAGR vs 32.8%).
Jazz Pharmaceuticals plc is a global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States and is now headquartered in Dublin, Ireland.
Westrock Coffee Co is a global integrated coffee, tea and functional beverage solutions provider. It sources, roasts, manufactures and distributes coffee products, ready-to-drink beverages and custom formulations for retail, foodservice and commercial clients across North America and other key markets.
AXSM vs WEST — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $196.0M | $339.5M |
| Net Profit | $-28.6M | $-22.6M |
| Gross Margin | — | 11.5% |
| Operating Margin | -13.8% | -2.6% |
| Net Margin | -14.6% | -6.6% |
| Revenue YoY | 65.0% | 48.3% |
| Net Profit YoY | 61.9% | 8.3% |
| EPS (diluted) | $-0.55 | $-0.22 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $196.0M | $339.5M | ||
| Q3 25 | $171.0M | $354.8M | ||
| Q2 25 | $150.0M | $280.9M | ||
| Q1 25 | $121.5M | $213.8M | ||
| Q4 24 | $118.8M | $229.0M | ||
| Q3 24 | $104.8M | $220.9M | ||
| Q2 24 | $87.2M | $208.4M | ||
| Q1 24 | $75.0M | $192.5M |
| Q4 25 | $-28.6M | $-22.6M | ||
| Q3 25 | $-47.2M | $-19.1M | ||
| Q2 25 | $-48.0M | $-21.6M | ||
| Q1 25 | $-59.4M | $-27.2M | ||
| Q4 24 | $-74.9M | $-24.6M | ||
| Q3 24 | $-64.6M | $-14.3M | ||
| Q2 24 | $-79.3M | $-17.8M | ||
| Q1 24 | $-68.4M | $-23.7M |
| Q4 25 | — | 11.5% | ||
| Q3 25 | — | 11.7% | ||
| Q2 25 | — | 14.7% | ||
| Q1 25 | — | 13.6% | ||
| Q4 24 | — | 16.6% | ||
| Q3 24 | — | 16.8% | ||
| Q2 24 | — | 19.9% | ||
| Q1 24 | — | 19.4% |
| Q4 25 | -13.8% | -2.6% | ||
| Q3 25 | -27.0% | -2.4% | ||
| Q2 25 | -24.5% | -5.3% | ||
| Q1 25 | -46.9% | -6.1% | ||
| Q4 24 | -61.1% | -4.3% | ||
| Q3 24 | -59.8% | -5.8% | ||
| Q2 24 | -89.5% | -7.9% | ||
| Q1 24 | -89.7% | -5.3% |
| Q4 25 | -14.6% | -6.6% | ||
| Q3 25 | -27.6% | -5.4% | ||
| Q2 25 | -32.0% | -7.7% | ||
| Q1 25 | -48.9% | -12.7% | ||
| Q4 24 | -63.1% | -10.7% | ||
| Q3 24 | -61.7% | -6.5% | ||
| Q2 24 | -91.0% | -8.5% | ||
| Q1 24 | -91.1% | -12.3% |
| Q4 25 | $-0.55 | $-0.22 | ||
| Q3 25 | $-0.94 | $-0.20 | ||
| Q2 25 | $-0.97 | $-0.23 | ||
| Q1 25 | $-1.22 | $-0.29 | ||
| Q4 24 | $-1.54 | $-0.26 | ||
| Q3 24 | $-1.34 | $-0.16 | ||
| Q2 24 | $-1.67 | $-0.20 | ||
| Q1 24 | $-1.44 | $-0.27 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $322.9M | $49.9M |
| Total DebtLower is stronger | — | $444.1M |
| Stockholders' EquityBook value | $88.3M | $-1.9M |
| Total Assets | $689.8M | $1.2B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $322.9M | $49.9M | ||
| Q3 25 | $325.3M | $34.0M | ||
| Q2 25 | $303.0M | $44.0M | ||
| Q1 25 | $300.9M | $33.1M | ||
| Q4 24 | $315.4M | $26.2M | ||
| Q3 24 | $327.3M | $22.4M | ||
| Q2 24 | $315.7M | $24.3M | ||
| Q1 24 | $331.4M | $12.6M |
| Q4 25 | — | $444.1M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $393.1M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $88.3M | $-1.9M | ||
| Q3 25 | $73.7M | $11.4M | ||
| Q2 25 | $73.1M | $18.2M | ||
| Q1 25 | $53.2M | $71.4M | ||
| Q4 24 | $57.0M | $97.5M | ||
| Q3 24 | $92.9M | $110.3M | ||
| Q2 24 | $102.9M | $81.5M | ||
| Q1 24 | $144.0M | $91.7M |
| Q4 25 | $689.8M | $1.2B | ||
| Q3 25 | $669.3M | $1.2B | ||
| Q2 25 | $639.8M | $1.2B | ||
| Q1 25 | $596.7M | $1.1B | ||
| Q4 24 | $568.5M | $1.1B | ||
| Q3 24 | $561.5M | $1.1B | ||
| Q2 24 | $548.2M | $1.1B | ||
| Q1 24 | $545.7M | $983.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 4.03× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-18.7M | $36.7M |
| Free Cash FlowOCF − Capex | $-18.7M | $27.8M |
| FCF MarginFCF / Revenue | -9.6% | 8.2% |
| Capex IntensityCapex / Revenue | 0.0% | 2.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-93.9M | $-107.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-18.7M | $36.7M | ||
| Q3 25 | $1.0M | $-26.6M | ||
| Q2 25 | $-32.4M | $-7.0M | ||
| Q1 25 | $-43.4M | $-22.1M | ||
| Q4 24 | $-26.2M | $2.8M | ||
| Q3 24 | $-18.6M | $-332.0K | ||
| Q2 24 | $-30.1M | $-23.7M | ||
| Q1 24 | $-53.5M | $8.0M |
| Q4 25 | $-18.7M | $27.8M | ||
| Q3 25 | $988.0K | $-44.7M | ||
| Q2 25 | $-32.4M | $-27.5M | ||
| Q1 25 | $-43.7M | $-63.4M | ||
| Q4 24 | $-26.2M | $-15.4M | ||
| Q3 24 | $-18.7M | $-36.7M | ||
| Q2 24 | $-30.2M | $-59.9M | ||
| Q1 24 | $-53.6M | $-60.9M |
| Q4 25 | -9.6% | 8.2% | ||
| Q3 25 | 0.6% | -12.6% | ||
| Q2 25 | -21.6% | -9.8% | ||
| Q1 25 | -36.0% | -29.7% | ||
| Q4 24 | -22.1% | -6.7% | ||
| Q3 24 | -17.9% | -16.6% | ||
| Q2 24 | -34.6% | -28.7% | ||
| Q1 24 | -71.4% | -31.7% |
| Q4 25 | 0.0% | 2.6% | ||
| Q3 25 | 0.0% | 5.1% | ||
| Q2 25 | 0.0% | 7.3% | ||
| Q1 25 | 0.3% | 19.3% | ||
| Q4 24 | 0.0% | 7.9% | ||
| Q3 24 | 0.1% | 16.5% | ||
| Q2 24 | 0.1% | 17.4% | ||
| Q1 24 | 0.1% | 35.8% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AXSM
Segment breakdown not available.
WEST
| Coffee And Tea | $202.6M | 60% |
| Flavors Extracts And Ingredients | $69.6M | 21% |
| Sustainable Sourcing And Traceability Segments | $66.9M | 20% |
